Literature DB >> 28729026

MicroRNAs in Oncogenesis and Tumor Suppression.

Simona Barbato1, Giancarlo Solaini1, Muller Fabbri2.   

Abstract

MicroRNAs (MiRNAs) have emerged in the last 15 years as central players in the biology of cancer. Increasing lines of evidence have supported their regulatory role in the expression of both oncogenes and tumor-suppressor genes, progressively clarifying which genes are modulated by specific MiRNAs dysregulated in cancer. Intriguingly, a "target-specific" understanding of MiRNA function in oncology has been replaced by a more "pathway-specific" vision of their involvement in cancer biology. This work provides a state-of-the-art knowledge of the role of MiRNAs in the most frequently altered signaling pathways in cancer cells and provides an updated overview on some of the most relevant findings trying to decode the complex molecular mechanisms of cancer.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; MicroRNAs; Oncogenes; Tumor-suppressor genes

Mesh:

Substances:

Year:  2017        PMID: 28729026     DOI: 10.1016/bs.ircmb.2017.05.001

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  22 in total

1.  Expression of miRNA in 5-FU resistant esophageal cancer.

Authors:  Prasit Mahawongkajit; Prakitpunthu Tomtitchong
Journal:  Mol Clin Oncol       Date:  2020-06-11

2.  Long noncoding RNA TOB1-AS1, an epigenetically silenced gene, functioned as a novel tumor suppressor by sponging miR-27b in cervical cancer.

Authors:  Jihang Yao; Zhenghong Li; Ziwei Yang; Hui Xue; Hua Chang; Xue Zhang; Tianren Li; Kejun Guo
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 3.  The role of LncRNA MCM3AP-AS1 in human cancer.

Authors:  Shirin Azizidoost; Farhoodeh Ghaedrahmati; Mohadeseh Sheykhi-Sabzehpoush; Shahab Uddin; Mehri Ghafourian; Abdolah Mousavi Salehi; Mona Keivan; Maryam Cheraghzadeh; Zahra Nazeri; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Clin Transl Oncol       Date:  2022-08-24       Impact factor: 3.340

4.  MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt/β-catenin signaling pathway in glioma.

Authors:  Chong Li; Shiyu Feng; Ling Chen
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

5.  MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function.

Authors:  Nianqing Wan; Jianxiao Zheng
Journal:  Oncol Lett       Date:  2021-05-02       Impact factor: 2.967

6.  Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis.

Authors:  Zhi-Qiang Gao; Jun-Feng Wang; De-Hua Chen; Xue-Song Ma; Yang Wu; Zhe Tang; Xiao-Wei Dang
Journal:  Cell Biosci       Date:  2017-12-04       Impact factor: 7.133

7.  Formononetin inhibits colon carcinoma cell growth and invasion by microRNA‑149‑mediated EphB3 downregulation and inhibition of PI3K/AKT and STAT3 signaling pathways.

Authors:  Ai-Lei Wang; Yong Li; Qun Zhao; Li-Qiao Fan
Journal:  Mol Med Rep       Date:  2018-04-05       Impact factor: 2.952

8.  An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.

Authors:  Dan Xue; Pu Cheng; Mengjiao Han; Xiyong Liu; Lijun Xue; Chenyi Ye; Ke Wang; Jian Huang
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

Review 9.  Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.

Authors:  Theresa L Whiteside; Brenda Diergaarde; Chang-Sook Hong
Journal:  Int J Mol Sci       Date:  2021-06-09       Impact factor: 5.923

10.  Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals.

Authors:  Zhenyu Ou; Yongjie Wang; Jinbo Chen; Le Tao; Li Zuo; Deepak Sahasrabudhe; Jean Joseph; Long Wang; Shuyuan Yeh
Journal:  Exp Mol Med       Date:  2018-11-20       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.